autism spectrum disorder
The study has demonstrated the potential of predictable movement stimuli as a behavioural marker of autism spectrum disorder.
The company will use the funds to grow its autism therapy practice, continue AI and LLM research, and develop clinical algorithms.
The funds will be used to accelerate the adoption of the platform's applied behavior analysis-focused tools.
EarliPoint Evaluation monitors a child's looking behavior while watching videos to help a clinician identify autism spectrum disorder.
The company also launched a Clinical Advisory Board to aid in the development of new programs for diverse populations.
Also: Opya scooped up $15.4 million, MiSalud raised $5 million and DocSpace announced $1.2 million in seed funding.
Canvas Dx is indicated as an aid in the diagnosis of ASD in patients between the ages 18 months and 5 years old who are at risk of developmental delay.
The company said that its tool was "highly accurate" in a 425-participant study conducted across 14 U.S. sites.
Designed for kids, the program includes games, a biofeedback wearable, a caregiver dashboard and regular clinician coaching.
The startup combines free assessments and in-person therapy with telehealth and digital care-coordination.